Efficacy and safety of once‐weekly exenatide after switching from twice‐daily exenatide in patients with type 2 diabetes

AIMS/INTRODUCTION: To evaluate the efficacy and safety of once‐weekly (q.w.) extended‐release exenatide after switching from twice‐daily (b.i.d.) exenatide in patients with type 2 diabetes. MATERIALS AND METHODS: This was an investigator‐initiated, prospective, single‐arm, multicenter study. Individ...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Yuusuke, Saisho, Yoshifumi, Inaishi, Jun, Kou, Kinsei, Yamauchi, Akira, Kanazawa, Yasuhiko, Okubo, Yoshiaki, Tokui, Mikiya, Imai, Takatoshi, Murakami, Rie, Tsuchiya, Tami, Sasaki, Hironobu, Masaoka, Tatsuhiro, Irie, Junichiro, Meguro, Shu, Itoh, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078076/
https://www.ncbi.nlm.nih.gov/pubmed/31518492
http://dx.doi.org/10.1111/jdi.13146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078076/
https://www.ncbi.nlm.nih.gov/pubmed/31518492
http://dx.doi.org/10.1111/jdi.13146

Ejemplares similares